Stay updated on PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial
Sign up to get notified when there's something new on the PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial page.

Latest updates to the PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check71 days agoChange DetectedThe webpage has added a section with helpful links provided by Pfizer, which includes information on how to obtain contact details for a nearby study center.SummaryDifference0.5%
- Check78 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes a new EudraCT number for a clinical trial related to SARS-CoV-2 infection, while significant details about the study's purpose and participant criteria have been removed.SummaryDifference24%
Stay in the know with updates to PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial page.